Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia - a Phase 4 Clinical Trial

NCT05760534 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05760534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05760534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia - a Phase 4 Clinical Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 6, 2023
Completion date
November 25, 2025
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis hip, arthritis knee